Quick Answer
ImageneBio, Inc. reported Stockholders Equity of $133.14 million for the year ending 2025.
- ImageneBio, Inc. showed an increase of +182.9% in Stockholders Equity from 2024 to 2025.
- This data is from ImageneBio, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2020: -$68.01 million | Q2 2020: -$72.70 million | Q3 2020: -$78.50 million | Q1 2021: $227.64 million | Q2 2021: $216.26 million | Q3 2021: $203.26 million | Q1 2022: $192.96 million | Q2 2022: $174.37 million | Q3 2022: $158.79 million | Q1 2023: $135.02 million | Q2 2023: $156.70 million | Q3 2023: $155.34 million | Q1 2024: -$137.35 million | Q2 2024: -$146.58 million | Q3 2024: -$152.75 million | Q1 2025: -$169.60 million | Q2 2025: -$180.35 million | Q3 2025: $139.83 million.
- Over the full 7 years of available data (2019 to 2025), ImageneBio, Inc.'s Stockholders Equity has grown by 316.6%.
- Historical annual values: Fiscal year 2025: $133.14 million | Fiscal year 2024: -$160.57 million | Fiscal year 2023: -$126.11 million | Fiscal year 2022: $146.97 million | Fiscal year 2021: $207.88 million | Fiscal year 2020: -$101.05 million | Fiscal year 2019: -$61.46 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: